志苓胶囊联合mFOLFOX6方案用于初治老年晚期直肠癌疗效及其安全性观察(4)
[12]Morimoto M，Miyakura Y，Lefor AT，et al.Reduction in the size of enlarged pelvic lymph nodes after chemoradiation therapy is associated with fewer lymph node metastases in locally advanced rectal carcinoma[J].Surg Today，2015，45(7)：834-840.
[13]Stoffregen CC，Odin EA，Carlsson GU，et al.Reduced folate and serum vitamin metabolites in patients with rectal carcinoma：an open-label feasibility study of pemetrexed with folic acid and vitamin B12 supplementation[J].Anticancer Drugs，2016，27(5)：439-446.
[14]Wen B，Zhang L，Wang C，et al.Prognostic significance of clinical and pathological stages on locally advanced rectal carcinomaafter neoadjuvant chemoradiotherapy[J].Radiat Oncol，2015，10(1)：124.
[15]Julio Garcia-Aguilar，Oliver S Chow，David D Smith，et al.Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer：a multicentre，phase 2 trial[J].Lancet Oncol，2015，16(8)：957-966.
[16]Yuji Toiyama，Yasuhiro Inoue，Takahito Kitajima，et al.Conversion Therapy Using mFOLFOX6 With Panitumumab for Unresectable Liver Metastases From Multiple Colorectal Cancers With Familial Adenomatous[J].PolyposisInt Surg，2014，99(6)：795-801.
[17]J Randolph Hecht，Edith P Mitchell，Takayuki Yoshino，et al.5-Fluorouracil，leucovorin，and oxaliplatin(mFOLFOX6)plus sunitinib or bevacizumab as first-line treatment for metastatic colorectal cancer：a randomized Phase IIb study[J].Cancer Manag Res，2015(7)：165-173.
[18]陳英玉，潘云苓，刘庭波，等.志苓胶囊对人小细胞肺癌细胞系NCI-H446增殖抑制和诱导凋亡的影响[J].中国中西医结合杂志，2007，27(6)：531-534.
[19]潘云苓，潘远志.志苓胶囊治疗中晚期肺癌的疗效观察[J].中国中西医结合杂志，2006，26(7)：604-607.
[20]郑志宏，潘云苓，陈英玉，等.志苓胶囊通过激活caspase-3抑制K562细胞增殖和诱导细胞凋亡[J].中国药理学通报，2009，25(9)：1244-1247., 百拇医药(蔡艳萍 薛顺和)
[13]Stoffregen CC，Odin EA，Carlsson GU，et al.Reduced folate and serum vitamin metabolites in patients with rectal carcinoma：an open-label feasibility study of pemetrexed with folic acid and vitamin B12 supplementation[J].Anticancer Drugs，2016，27(5)：439-446.
[14]Wen B，Zhang L，Wang C，et al.Prognostic significance of clinical and pathological stages on locally advanced rectal carcinomaafter neoadjuvant chemoradiotherapy[J].Radiat Oncol，2015，10(1)：124.
[15]Julio Garcia-Aguilar，Oliver S Chow，David D Smith，et al.Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer：a multicentre，phase 2 trial[J].Lancet Oncol，2015，16(8)：957-966.
[16]Yuji Toiyama，Yasuhiro Inoue，Takahito Kitajima，et al.Conversion Therapy Using mFOLFOX6 With Panitumumab for Unresectable Liver Metastases From Multiple Colorectal Cancers With Familial Adenomatous[J].PolyposisInt Surg，2014，99(6)：795-801.
[17]J Randolph Hecht，Edith P Mitchell，Takayuki Yoshino，et al.5-Fluorouracil，leucovorin，and oxaliplatin(mFOLFOX6)plus sunitinib or bevacizumab as first-line treatment for metastatic colorectal cancer：a randomized Phase IIb study[J].Cancer Manag Res，2015(7)：165-173.
[18]陳英玉，潘云苓，刘庭波，等.志苓胶囊对人小细胞肺癌细胞系NCI-H446增殖抑制和诱导凋亡的影响[J].中国中西医结合杂志，2007，27(6)：531-534.
[19]潘云苓，潘远志.志苓胶囊治疗中晚期肺癌的疗效观察[J].中国中西医结合杂志，2006，26(7)：604-607.
[20]郑志宏，潘云苓，陈英玉，等.志苓胶囊通过激活caspase-3抑制K562细胞增殖和诱导细胞凋亡[J].中国药理学通报，2009，25(9)：1244-1247., 百拇医药(蔡艳萍 薛顺和)